All companies
500 S&P 500 companies, 1459 sets of results in total. Market cap and share price are always in view; switch the third column between revenue, profit and margin, or sort by any column.
| # | Company | Market cap | Share price | Revenue |
|---|---|---|---|---|
| 351 |
|
$17.1B | $28.40 +2.4% | $21.1B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 |
| 352 |
|
$17.0B | $230.45 −1.4% | $3.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 |
| 353 |
|
$16.7B | $115.18 +1.3% | $4.1B Last four quarters 2025: Q1, Q2, Q3 · 2024: Q4 |
| 354 |
|
$16.6B | $297.78 +0.9% | $2.8B Last four quarters 2026: Q1, Q2 · 2025: Q2, Q3 |
| 355 |
|
$16.5B | $27.45 +0.6% | $4.7B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 |
| 356 |
|
$16.1B | $30.77 +1.9% | $3.6B 1 of four quarters 2026: Q1 |
| 357 |
|
$15.9B | $134.93 +1.6% | $13.1B Last four quarters 2026: Q1, Q2 · 2025: Q2, Q4 |
| 358 |
|
$15.8B | $137.20 +0.7% | $3.0B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 |
| 359 |
|
$15.4B | $240.09 +0.5% | $13.8B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 |
| 360 | DOC Healthpeak Properties | $15.1B | $21.83 −1.0% | $2.8B Last four quarters 2025: Q1, Q2, Q3 · 2024: Q3 |
| 361 |
|
$14.8B | $85.44 −1.6% | $8.2B Last four quarters 2026: Q1 · 2025: Q1, Q2, Q4 |
| 362 |
|
$14.7B | $80.29 −0.1% | $0.41B 1 of four quarters 2026: Q1 |
| 363 |
|
$14.5B | $115.60 +2.8% | $17.2B Last four quarters 2026: Q1 · 2025: Q2 · 2024: Q3, Q4 |
| 364 |
|
$14.4B | $415.88 −0.4% | $5.1B Last four quarters 2026: Q1 · 2025: Q1 · 2024: Q3, Q4 |
| 365 |
|
$14.3B | $94.58 −1.0% | $15.5B Last four quarters 2026: Q1, Q2 · 2025: Q2, Q3 |
| 366 |
|
$14.2B | $182.25 −0.4% | $1.6B 1 of four quarters 2026: Q1 |
| 367 | COO Cooper Companies (The) | $14.1B | $72.32 −0.5% | $4.1B Last four quarters 2026: Q2 · 2025: Q1, Q2, Q3 |
| 368 |
|
$14.1B | $71.48 −0.9% | $7.7B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 |
| 369 | ZBRA Zebra Technologies | $14.0B | $293.82 +1.8% | $5.6B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 |
| 370 |
|
$13.9B | $117.64 −0.1% | $5.3B Last four quarters 2026: Q1 · 2025: Q1, Q2, Q4 |
| 371 |
|
$13.8B | $279.19 −1.2% | $3.4B 1 of four quarters 2026: Q1 |
| 372 |
|
$13.8B | $25.01 −1.4% | $12.3B Last four quarters 2026: Q2 · 2025: Q1, Q4 · 2024: Q4 |
| 373 |
|
$13.7B | $50.90 −0.1% | $7.1B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 |
| 374 | BAX Baxter International | $13.5B | $26.16 −2.2% | $11.5B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 |
| 375 | ALLE Allegion | $13.4B | $157.40 +0.2% | $4.3B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 |
New results in your inbox
When a big company reports, you get the diagram before anyone has time to comment on it. No spam, one-click unsubscribe.